Allotment of 3,85,10,000 warrants pursuant to Preferential Issue
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 10.8 pts more than Nifty Microcap 250 and 10.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
SPARC's Securities Allotment Committee approved and allotted 3,85,10,000 convertible warrants to Shanghvi Finance Private Limited at INR 155.80 per warrant on a preferential basis. The company received INR 149.99 crore as 25% upfront payment (minimum required under SEBI ICDR regulations), with the balance payable upon conversion. Each warrant is convertible into one fully paid-up equity share of face value INR 1. The paid-up capital remains unchanged for now but will increase upon warrant conversion. The preferential issue was approved by the Board on January 14, 2026, and by shareholders at an EOGM on February 9, 2026, with in-principle exchange approvals obtained on May 8, 2026.
This is a related-party preferential allotment with significant dilution potential — once warrants convert, the company will issue ~38.5 crore new equity shares, substantially diluting existing shareholders. The INR 150 crore inflow provides near-term capital without immediate equity dilution.